Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Hematronix, Inc. — Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

48 daysmedian FDA review time
368 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K012243MCC URICHECK ASSAYED LIQUID URINE MULTICONSTITUENT CONTROLHematronix, Inc.2001-08-20340
K993496RETIC-QUINOXHematronix, Inc.1999-11-30460
K972710QUANTIFY(901)Hematronix, Inc.1997-08-15250
K960471TRI-COUNT 20Hematronix, Inc.1996-03-20480
K960005TRI-COURT 20-THematronix, Inc.1996-03-19770
K941965EZ-RANGEHematronix, Inc.1995-04-253680
K935343CENTRIFIQ BLOOD CONTROLHematronix, Inc.1994-01-271280
K904461METER TRAXHematronix, Inc.1990-10-26250
K902389TRI-COUNT 16Hematronix, Inc.1990-08-22840

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda